Thomas Hong | IR |
Jacqueline Shea | CEO, President & Director |
Michael Sumner | Chief Medical Officer |
David Liebowitz | SVP, Clinical Development |
Jeffrey Skolnik | SVP, Clinical Development |
Peter Kies | CFO |
Alexandria Hammond | Bank of America Merrill Lynch |
Gregory Renza | RBC Capital Markets |
Jiale Song | Jefferies |
Eka Gigauri | Oppenheimer |
Raghuram Selvaraju | H.C. Wainwright & Co. |
Yi Chen | H.C. Wainwright & Co. |
Good afternoon, and welcome to the Inovio Pharmaceuticals conference call. [Operator Instructions]. Please note, this event is being recorded. I would now like to turn the conference over to Thomas Hong, Manager of Investor Relations. Please go ahead.